Publication date: Jan 16, 2025
The progression of melanoma is a complex process influenced by both internal and external cues which encourage the transition of tumour cells, uncontrolled growth, migration, and metastasis. Additionally, inflammation allows tumours to evade the immune system, contributing to cancer development. The inflammasome, a complex of many proteins, is crucial in enhancing immune responses to external and internal triggers. As a critical inflammatory mechanism, it contributes to the development of melanoma. These mechanisms may be triggered via various internal and external stimuli, causing the induction of specific enzymes such as caspase-1, caspase-11, or caspase-8. This, in turn, leads to the release of interleukin (IL)-1β and IL-18 and cell death by apoptosis and pyroptosis. Proper inflammasome stimulation is crucial for the host to deal with invading pathogens or tissue injury. However, inappropriate inflammasome stimulation can result in unregulated tissue reactions, thus easing many diseases, including melanoma. Hence, keeping a delicate equilibrium between the stimulation and prohibition of inflammasomes is crucial, necessitating meticulous control of the assembly and functional aspects of inflammasomes. This review examines the latest advancements in inflammasome studies, specifically focusing on the molecular processes that control inflammasome formation, signalling, and modulation in melanoma.
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | melanoma |
pathway | KEGG | Melanoma |
disease | MESH | metastasis |
disease | MESH | inflammation |
pathway | REACTOME | Immune System |
disease | MESH | cancer |
pathway | REACTOME | Release |
pathway | REACTOME | Apoptosis |
pathway | REACTOME | Pyroptosis |
pathway | REACTOME | Inflammasomes |
disease | MESH | Disease Progression |
pathway | REACTOME | Signal Transduction |
disease | MESH | Skin Neoplasms |